The Use of Erythropoietin and its Derivatives to Treat Spinal Cord Injury

E-ISSN： 1875-5607|11|9|763-770

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.11, Iss.9, 2011-08, pp. : 763-770

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hedgehog and spinal cord injury

By Williams Juliet A

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1137-1145

Informa Healthcare

Access to resources Recommend Favorite

Spinal Cord Ischemia/Injury

Current Pharmaceutical Design, Vol. 20, Iss. 36, 2014-11 ,pp. : 5738-5743

Bentham Science Publishers

Access to resources Recommend Favorite

Recombinant Human Erythropoietin Protects Against Experimental Spinal Cord Trauma Injury by Regulating Expression of the Proteins MKP-1 and p-ERK

By Huang H Fan S Ji X Zhang Y Bao F Zhang G

The Journal of International Medical Research, Vol. 37, Iss. 2, 2009-03 ,pp. : 511-519

Field House Publishing

Access to resources Recommend Favorite

Emerging drugs for spinal cord injury

By Baptiste Darryl C Fehlings Michael G

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 63-80

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy Strategies for Spinal Cord Injury

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 6, 2015-06 ,pp. : 492-505

Bentham Science Publishers

Access to resources Recommend Favorite